Centene
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 100.62% -0.06pp
- Institutions
- 1,319 -6
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| Frederick Eppinger | Independent Chairperson | 0.07% |
| Andrew Asher | Chief Financial Officer | 0.06% |
| Sarah London | Chief Executive Officer | 0.06% |
| Kenneth Burdick | Former Director | 0.06% |
| Kenneth Fasola | Former Advisor | 0.02% |
| Theodore Samuels | Independent Director | 0.01% |
| H. Dallas | Lead Independent Director | 0.01% |
| Christopher Coughlin | Independent Director | 0.01% |
| Katie Casso | Senior Vice President of Finance Operations & Innovation | 0.01% |
| Susan Smith | Chief Operating Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-14 | Michael Carson | Group President of Medicare & Specialty | Sale to Issuer | -7,130 | $70.16 |
| 2026-09-29 | Lauren Tyler | Director | Other Acquisition | +482 | -- |
| 2026-09-29 | Frederick Eppinger | Independent Chairperson | Other Acquisition | +864 | -- |
| 2026-09-29 | Christopher Coughlin | Independent Director | Other Acquisition | +583 | -- |
| 2026-09-29 | Theodore Samuels | Independent Director | Other Acquisition | +583 | -- |
| 2026-09-29 | Kenneth Tanji | Independent Director | Other Acquisition | +603 | -- |
| 2026-09-14 | Theodore Pienkos | Corporate Controller & Chief Accounting Officer | Sale to Issuer | -1,092 | $69.41 |
| 2026-08-25 | Kenneth Burdick | Former Director | Intent to Sell (Form 144) | -43,600 | $65.00 |
| 2026-08-25 | Christopher Koster | General Counsel | Open Market Disposition | -56,500 | $66.90 |
| 2026-08-17 | Christopher Koster | General Counsel | Open Market Disposition | -47,603 | $65.36 |
| 2026-08-04 | Kenneth Burdick | Former Director | Intent to Sell (Form 144) | -100,000 | $68.15 |
| 2026-07-27 | Paul Diaz | Director | Other Acquisition | +2,771 | -- |
| 2026-07-16 | Lauren Tyler | Director | Other Acquisition | +3,155 | -- |
| 2026-06-29 | Lauren Tyler | Director | Other Acquisition | +61 | -- |
| 2026-06-29 | Frederick Eppinger | Independent Chairperson | Other Acquisition | +833 | -- |
| 2026-06-29 | Christopher Coughlin | Independent Director | Other Acquisition | +562 | -- |
| 2026-06-29 | Theodore Samuels | Independent Director | Other Acquisition | +465 | -- |
| 2026-06-29 | Kenneth Tanji | Independent Director | Other Acquisition | +581 | -- |
| 2026-06-14 | Susan Smith | Chief Operating Officer | Sale to Issuer | -483 | $65.19 |
| 2026-06-09 | Kenneth Burdick | Former Director | Open Market Disposition | -80,000 | $64.55 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:01:28 · For reference only, not investment advice and not tailored to your situation.
Centene discussion 0 comments